ANGN: Angion Biomedica Corp. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Angion Biomedica Corp.

NASDAQ:ANGN

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$10.00
Loss Chance
58.4%
1.00JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
The Central and Eastern Europe Fund
NYSE:CEE
4.41
$8.07
53.66%
United States Commodity Index Funds Trust - United States Copper Index Fund
NYSE:CPER
3.32
$20.84
38.04%
Invesco DB Commodity Index Tracking Fund
NYSE:DBC
2.67
$25.19
16.43%
Guggenheim Strategic Opportunities Fund
NYSE:GOF
4.18
$17.02
14.82%
iShares S&P GSCI Commodity-Indexed Trust
NYSE:GSG
2.61
$21.72
28.20%
Jitta Factors
Growth Opportunity (27)
Recent Business Performance (28)
Financial Strength (27)
Return to Shareholders (2)
Competitive Advantage (19)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Recent IPOLess than 3 years
Revenue and EarningEarning loss detected in 2022
Operating MarginDeclined
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.00
100.00%
2.43
385.32%
2.43
385.32%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of June 1, 2023, Angion Biomedica Corp. was acquired by Elicio Therapeutics, Inc., in a reverse merger transaction. Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York.
www.angion.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.